LIABILITY

I&D

Innovation is the lifeblood of enterprise development
Innovation is the eternal theme of enterprise and the lifeline of enterprise development. It is also the inexhaustible driving force and source of enterprise's sustainable and healthy development. As a high investment, high risk and high output industry, the continuous innovation of pharmaceutical industry plays a vital role in the development of enterprises. In particular, technological innovation is of great significance to the development of pharmaceutical enterprises.
On February 4, 2017, the national development and reform commission issued "catalog for the guidance of strategic emerging industries focus on products and services for the 2016 version, involving the field of strategic emerging industries 5 eight industries, 40 key under the direction of 174 is a direction, nearly 4000 niche products and services. Among them, new treatments such as new vaccines, antibody drugs, cells and gene therapy are particularly pointed out in the biomedical industry.
Chinese medicine enterprise management association ming-de yu said, "innovation medicine in 'much starker choices-and graver consequences-in planning, it can be seen that the national for drug development emphasis has risen to the strategic level, China pharmaceutical innovation will usher in a new stage of development."
The development guidance of emerging industries is clear, and innovative drugs are the big trend of long-term development, which is good for enterprises with innovative r&d ability.